These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17463463)

  • 21. Up to date review of the secondary preventive measures for recurrent ischaemic stroke and transient ischaemic episodes.
    Gibbs CR; Li-Saw-Hee FL; Lip GY
    Scott Med J; 1998 Feb; 43(1):6. PubMed ID: 9533251
    [No Abstract]   [Full Text] [Related]  

  • 22. What is the best first agent to give to a patient with acute ischaemic stroke? Aspirin, heparin, clopidogrel, cilostazol or dipyridamole?
    Khan M; Kamal AK
    J Pak Med Assoc; 2010 Oct; 60(10):877-8. PubMed ID: 21381628
    [No Abstract]   [Full Text] [Related]  

  • 23. [Secondary prevention after stroke. 2 platelet inhibitors are better than one].
    MMW Fortschr Med; 2002 May; 144(19):61. PubMed ID: 12116558
    [No Abstract]   [Full Text] [Related]  

  • 24. Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA.
    Johnston SC; Easton JD; Farrant M; Barsan W; Conwit RA; Elm JJ; Kim AS; Lindblad AS; Palesch YY;
    N Engl J Med; 2018 Jul; 379(3):215-225. PubMed ID: 29766750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dipyridamole plus aspirin: the best regimen for stroke prevention after noncardioembolic focal cerebral ischemia.
    Jonas S; Grieco G
    Cerebrovasc Dis; 2006; 22(1):1-3. PubMed ID: 16567930
    [No Abstract]   [Full Text] [Related]  

  • 26. [Secondary prevention of ischemic insult and transient cerebral ischemia. Is ASS alone enough?].
    Diener HC
    MMW Fortschr Med; 2003 May; 145 Suppl 2():111. PubMed ID: 14579505
    [No Abstract]   [Full Text] [Related]  

  • 27. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
    Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secondary stroke prevention with antiplatelet therapy with emphasis on the cardiac patient: a neurologist's view.
    Gebel JM
    J Am Coll Cardiol; 2005 Sep; 46(5):752-5. PubMed ID: 16139120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative evaluation of treatment with low-dose aspirin plus dipyridamole versus aspirin only in patients with acute ischaemic stroke.
    Arnarsdottir L; Hjalmarsson C; Bokemark L; Andersson B
    BMC Neurol; 2012 Aug; 12():67. PubMed ID: 22866821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aspirin plus dipyridamole versus aspirin for prevention of vascular events after stroke or TIA: a meta-analysis.
    Verro P; Gorelick PB; Nguyen D
    Stroke; 2008 Apr; 39(4):1358-63. PubMed ID: 18323511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clopidogrel and aspirin after ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized clinical trials.
    Kheiri B; Osman M; Abdalla A; Haykal T; Swaid B; Ahmed S; Chahine A; Hassan M; Bachuwa G; Al Qasmi M; Bhatt DL
    J Thromb Thrombolysis; 2019 Feb; 47(2):233-247. PubMed ID: 30511260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose and high-dose acetylsalicylic acid, with and without dipyridamole: a review of clinical trial results.
    Tijssen JG
    Neurology; 1998 Sep; 51(3 Suppl 3):S15-6. PubMed ID: 9744825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiplatelet treatment for secondary prevention of acute ischemic stroke and transient ischemic attacks: mechanisms, choices and possible emerging patterns of use.
    Moonis M; Fisher M
    Expert Rev Cardiovasc Ther; 2003 Nov; 1(4):611-5. PubMed ID: 15030260
    [No Abstract]   [Full Text] [Related]  

  • 34. Dipyridamole plus aspirin versus aspirin alone in secondary prevention after TIA or stroke: a meta-analysis by risk.
    Halkes PH; Gray LJ; Bath PM; Diener HC; Guiraud-Chaumeil B; Yatsu FM; Algra A
    J Neurol Neurosurg Psychiatry; 2008 Nov; 79(11):1218-23. PubMed ID: 18535024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination shows no advantage over aspirin alone.
    Gogol M
    BMJ; 2007 May; 334(7602):1020. PubMed ID: 17510117
    [No Abstract]   [Full Text] [Related]  

  • 36. The PRoFESS trial: future impact on secondary stroke prevention.
    Diener HC
    Expert Rev Neurother; 2007 Sep; 7(9):1085-91. PubMed ID: 17868007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial.
    Dengler R; Diener HC; Schwartz A; Grond M; Schumacher H; Machnig T; Eschenfelder CC; Leonard J; Weissenborn K; Kastrup A; Haberl R;
    Lancet Neurol; 2010 Feb; 9(2):159-66. PubMed ID: 20060783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of new antiplatelet regimens used as secondary prevention of stroke or transient ischemic attack.
    Sarasin FP; Gaspoz JM; Bounameaux H
    Arch Intern Med; 2000 Oct; 160(18):2773-8. PubMed ID: 11025787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Albers GW; Amarenco P; Easton JD; Sacco RL; Teal P
    Chest; 2008 Jun; 133(6 Suppl):630S-669S. PubMed ID: 18574275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.